DHP India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 14, 2025, 10:52 pm

Quick Insight

DHP India Ltd, operating in the Oil Equipment & Services industry, presents a mixed financial picture with a P/E ratio of 31.1, indicating a relatively high valuation compared to its peers. The company's low ROE and ROCE of 2.84% and 3.43% respectively suggest inefficiencies in capital utilization. However, with a healthy OPM of 20% and a strong ICR of 358.50x, DHP India Ltd demonstrates good operational profitability and debt-servicing capability. The low P/BV ratio of 0.62x may indicate undervaluation, presenting a potential buying opportunity for investors seeking long-term value. Overall, despite certain weaknesses, the company's operational efficiency and financial stability provide a foundation for growth and shareholder value in the future.

Competitors of DHP India Ltd

All Competitor Stocks of DHP India Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:18 am

Below is a detailed analysis of the quarterly data for DHP India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Dec 2024) to 20.00 Cr., marking an increase of 6.00 Cr..
• For Expenses, as of Mar 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Dec 2024) to 16.00 Cr., marking an increase of 4.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Dec 2024) to 4.00 Cr., marking an increase of 2.00 Cr..
• For OPM %, as of Mar 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Dec 2024) to 20.00%, marking an increase of 5.00%.
• For Other Income, as of Mar 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2024) to 74.00 Cr., marking an increase of 74.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Dec 2024) to 77.00 Cr., marking an increase of 76.00 Cr..
• For Tax %, as of Mar 2025, the value is 15.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Dec 2024) to 15.00%, marking a decrease of 9.00%.
• For Net Profit, as of Mar 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Dec 2024) to 65.00 Cr., marking an increase of 64.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 215.83. The value appears strong and on an upward trend. It has increased from 3.27 (Dec 2024) to 215.83, marking an increase of 212.56.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:09 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:26 pm

Below is a detailed analysis of the balance sheet data for DHP India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
• For Reserves, as of Mar 2025, the value is 235.00 Cr.. The value appears strong and on an upward trend. It has increased from 214.00 Cr. (Mar 2024) to 235.00 Cr., marking an increase of 21.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing). It has decreased from 11.00 Cr. (Mar 2024) to 8.00 Cr., marking a decrease of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 250.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 233.00 Cr. (Mar 2024) to 250.00 Cr., marking an increase of 17.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2024) to 29.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 169.00 Cr..
• For Other Assets, as of Mar 2025, the value is 221.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2024) to 221.00 Cr., marking an increase of 184.00 Cr..
• For Total Assets, as of Mar 2025, the value is 250.00 Cr.. The value appears strong and on an upward trend. It has increased from 233.00 Cr. (Mar 2024) to 250.00 Cr., marking an increase of 17.00 Cr..

Notably, the Reserves (235.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for DHP India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 221.78. This value is within the healthy range. It has increased from 88.02 (Mar 24) to 221.78, marking an increase of 133.76.
• For Diluted EPS (Rs.), as of Mar 25, the value is 221.78. This value is within the healthy range. It has increased from 88.02 (Mar 24) to 221.78, marking an increase of 133.76.
• For Cash EPS (Rs.), as of Mar 25, the value is 233.76. This value is within the healthy range. It has increased from 100.29 (Mar 24) to 233.76, marking an increase of 133.47.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 793.62. It has increased from 722.88 (Mar 24) to 793.62, marking an increase of 70.74.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 793.62. It has increased from 722.88 (Mar 24) to 793.62, marking an increase of 70.74.
• For Dividend / Share (Rs.), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 4.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 192.58. It has increased from 177.39 (Mar 24) to 192.58, marking an increase of 15.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 275.69. This value is within the healthy range. It has increased from 114.37 (Mar 24) to 275.69, marking an increase of 161.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is 263.71. This value is within the healthy range. It has increased from 102.09 (Mar 24) to 263.71, marking an increase of 161.62.
• For PBT / Share (Rs.), as of Mar 25, the value is 262.94. This value is within the healthy range. It has increased from 101.70 (Mar 24) to 262.94, marking an increase of 161.24.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 221.78. This value is within the healthy range. It has increased from 88.02 (Mar 24) to 221.78, marking an increase of 133.76.
• For PBDIT Margin (%), as of Mar 25, the value is 143.15. This value is within the healthy range. It has increased from 64.47 (Mar 24) to 143.15, marking an increase of 78.68.
• For PBIT Margin (%), as of Mar 25, the value is 136.93. This value exceeds the healthy maximum of 20. It has increased from 57.55 (Mar 24) to 136.93, marking an increase of 79.38.
• For PBT Margin (%), as of Mar 25, the value is 136.53. This value is within the healthy range. It has increased from 57.33 (Mar 24) to 136.53, marking an increase of 79.20.
• For Net Profit Margin (%), as of Mar 25, the value is 115.16. This value exceeds the healthy maximum of 10. It has increased from 49.61 (Mar 24) to 115.16, marking an increase of 65.55.
• For Return on Networth / Equity (%), as of Mar 25, the value is 27.94. This value is within the healthy range. It has increased from 12.17 (Mar 24) to 27.94, marking an increase of 15.77.
• For Return on Capital Employeed (%), as of Mar 25, the value is 33.22. This value is within the healthy range. It has increased from 13.71 (Mar 24) to 33.22, marking an increase of 19.51.
• For Return On Assets (%), as of Mar 25, the value is 26.62. This value is within the healthy range. It has increased from 11.32 (Mar 24) to 26.62, marking an increase of 15.30.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.23. It has decreased from 0.25 (Mar 24) to 0.23, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 18.68. This value exceeds the healthy maximum of 3. It has decreased from 21.05 (Mar 24) to 18.68, marking a decrease of 2.37.
• For Quick Ratio (X), as of Mar 25, the value is 16.71. This value exceeds the healthy maximum of 2. It has decreased from 18.62 (Mar 24) to 16.71, marking a decrease of 1.91.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 4. It has increased from 0.99 (Mar 24) to 1.21, marking an increase of 0.22.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.54 (Mar 24) to 0.00, marking a decrease of 4.54.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.98 (Mar 24) to 0.00, marking a decrease of 3.98.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.46 (Mar 24) to 0.00, marking a decrease of 95.46.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.02 (Mar 24) to 0.00, marking a decrease of 96.02.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 358.50. This value is within the healthy range. It has increased from 293.50 (Mar 24) to 358.50, marking an increase of 65.00.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 289.40. This value is within the healthy range. It has increased from 226.87 (Mar 24) to 289.40, marking an increase of 62.53.
• For Enterprise Value (Cr.), as of Mar 25, the value is -31.75. It has decreased from 205.58 (Mar 24) to -31.75, marking a decrease of 237.33.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 1. It has decreased from 3.86 (Mar 24) to -0.54, marking a decrease of 4.40.
• For EV / EBITDA (X), as of Mar 25, the value is -0.38. This value is below the healthy minimum of 5. It has decreased from 5.99 (Mar 24) to -0.38, marking a decrease of 6.37.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.58. This value is within the healthy range. It has decreased from 3.82 (Mar 24) to 2.58, marking a decrease of 1.24.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 95.45 (Mar 24) to 0.00, marking a decrease of 95.45.
• For Price / BV (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.93 (Mar 24) to 0.62, marking a decrease of 0.31.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.58. This value is within the healthy range. It has decreased from 3.82 (Mar 24) to 2.58, marking a decrease of 1.24.
• For EarningsYield, as of Mar 25, the value is 0.44. This value is below the healthy minimum of 5. It has increased from 0.13 (Mar 24) to 0.44, marking an increase of 0.31.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness